Collegium Pharmaceutical, Inc. Increase (Decrease) in Inventories
Collegium Pharmaceutical, Inc. (COLL) reported Increase (Decrease) in Inventories of $2.43 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-06
- Collegium Pharmaceutical, Inc. increase (decrease) in inventories for the quarter ending 2026-06-30 was $597.00K, a 35.81% decline year-over-year.
- Collegium Pharmaceutical, Inc. increase (decrease) in inventories for the quarter ending 2026-03-31 was $1.83M, a 10.31% increase year-over-year.
- Collegium Pharmaceutical, Inc. increase (decrease) in inventories for the quarter ending 2025-12-31 was $2.86M.
- Collegium Pharmaceutical, Inc. increase (decrease) in inventories for the quarter ending 2025-09-30 was -$96.00K.
- Collegium Pharmaceutical, Inc. increase (decrease) in inventories for fiscal 2025 was $5.35M.
- Collegium Pharmaceutical, Inc. increase (decrease) in inventories for fiscal 2024 was -$13.93M.
- Collegium Pharmaceutical, Inc. increase (decrease) in inventories for fiscal 2023 was -$14.17M.
- Collegium Pharmaceutical, Inc. increase (decrease) in inventories for fiscal 2022 was -$48.27M, a 2202.53% decline from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 3 month as first filed | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 6 month as first filed | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 9 month as first filed | Increase (Decrease) in Inventories 12 month | Increase (Decrease) in Inventories 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $597.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.43M 10-Q · filed 2026-08-06 | $5.29M derived: sum of 3 quarters · filed 2026-08-06 | $5.19M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $1.83M 10-Q · filed 2026-05-07 | $4.69M derived: sum of 2 quarters · filed 2026-05-07 | $4.59M derived: sum of 3 quarters · filed 2026-05-07 | $5.52M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $2.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.77M derived: sum of 2 quarters · filed 2026-02-26 | $3.69M derived: sum of 3 quarters · filed 2026-08-06 | $5.35M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | -$96.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $834.00K derived: sum of 2 quarters · filed 2026-08-06 | $2.49M 10-Q · filed 2025-11-06 | $20.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $930.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.59M 10-Q · filed 2026-08-06 | $116.00K derived: sum of 3 quarters · filed 2026-08-06 | -$6.87M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $1.66M 10-Q · filed 2026-05-07 | -$814.00K derived: sum of 2 quarters · filed 2026-05-07 | -$7.80M derived: sum of 3 quarters · filed 2026-05-07 | -$11.21M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | -$2.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$9.46M derived: sum of 2 quarters · filed 2026-02-26 | -$12.87M derived: sum of 3 quarters · filed 2026-02-26 | -$13.93M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | -$6.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$10.40M derived: sum of 2 quarters · filed 2025-11-06 | -$11.46M 10-Q · filed 2025-11-06 | -$13.25M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | -$3.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$4.47M 10-Q · filed 2025-08-07 | -$6.26M derived: sum of 3 quarters · filed 2026-02-26 | $1.84M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | -$1.06M 10-Q · filed 2025-05-08 | -$2.85M derived: sum of 2 quarters · filed 2026-02-26 | $5.25M derived: sum of 3 quarters · filed 2026-02-26 | -$1.62M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | -$1.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $6.31M derived: sum of 2 quarters · filed 2026-02-26 | -$563.00K derived: sum of 3 quarters · filed 2026-02-26 | -$14.17M 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | $8.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $1.23M derived: sum of 2 quarters · filed 2024-11-07 | -$12.38M 10-Q · filed 2024-11-07 | -$30.53M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-06-30 | -$6.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$20.48M 10-Q · filed 2024-08-08 | -$38.63M derived: sum of 3 quarters · filed 2025-02-27 | -$51.74M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-03-31 | -$13.61M 10-Q · filed 2024-05-09 | -$31.76M derived: sum of 2 quarters · filed 2025-02-27 | -$44.87M derived: sum of 3 quarters · filed 2025-02-27 | -$61.55M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2022-12-31 | -$18.15M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$31.27M derived: sum of 2 quarters · filed 2025-02-27 | -$47.94M derived: sum of 3 quarters · filed 2025-02-27 | -$48.27M 10-K · filed 2025-02-27 | ||||
| 2022-09-30 | -$13.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$29.79M derived: sum of 2 quarters · filed 2023-11-07 | -$30.12M 10-Q · filed 2023-11-07 | -$30.09M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-06-30 | -$16.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$17.01M 10-Q · filed 2023-08-03 | -$16.97M derived: sum of 3 quarters · filed 2024-02-22 | -$19.21M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-03-31 | -$330.00K 10-Q · filed 2023-05-04 | -$294.00K derived: sum of 2 quarters · filed 2024-02-22 | -$2.53M derived: sum of 3 quarters · filed 2024-02-22 | $1.57M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2021-12-31 | $36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$2.20M derived: sum of 2 quarters · filed 2024-02-22 | $1.90M derived: sum of 3 quarters · filed 2024-02-22 | $2.30M 10-K · filed 2024-02-22 | ||||
| 2021-09-30 | -$2.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $1.86M derived: sum of 2 quarters · filed 2022-11-03 | $2.26M 10-Q · filed 2022-11-03 | $1.22M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-06-30 | $4.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $4.50M 10-Q · filed 2022-08-04 | $3.45M derived: sum of 3 quarters · filed 2023-02-23 | $2.98M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-03-31 | $400.00K 10-Q · filed 2022-05-10 | -$645.00K derived: sum of 2 quarters · filed 2023-02-23 | -$1.11M derived: sum of 3 quarters · filed 2023-02-23 | $1.96M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2020-12-31 | -$1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -$1.51M derived: sum of 2 quarters · filed 2023-02-23 | $1.56M derived: sum of 3 quarters · filed 2023-02-23 | $8.27M 10-K · filed 2023-02-23 | ||||
| 2020-09-30 | -$470.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $2.60M derived: sum of 2 quarters · filed 2021-11-04 | $9.31M 10-Q · filed 2021-11-04 | $10.20M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-06-30 | $3.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $9.79M 10-Q · filed 2021-08-05 | $10.67M derived: sum of 3 quarters · filed 2022-02-24 | $9.47M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-03-31 | $6.71M 10-Q · filed 2021-05-06 | $7.60M derived: sum of 2 quarters · filed 2022-02-24 | $6.40M derived: sum of 3 quarters · filed 2022-02-24 | $7.62M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2019-12-31 | $883.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$310.00K derived: sum of 2 quarters · filed 2022-02-24 | $902.00K derived: sum of 3 quarters · filed 2022-02-24 | $1.83M 10-K · filed 2022-02-24 | ||||
| 2019-09-30 | -$1.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $19.00K derived: sum of 2 quarters · filed 2020-11-05 | $943.00K 10-Q · filed 2020-11-05 | -$469.00K derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | $1.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $2.14M 10-Q · filed 2020-08-05 | $724.00K derived: sum of 3 quarters · filed 2021-02-25 | $1.41M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | $924.00K 10-Q · filed 2020-05-07 | -$488.00K derived: sum of 2 quarters · filed 2021-02-25 | $197.00K derived: sum of 3 quarters · filed 2021-02-25 | $839.00K derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | -$1.41M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$727.00K derived: sum of 2 quarters · filed 2021-02-25 | -$85.00K derived: sum of 3 quarters · filed 2021-02-25 | -$219.00K 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | $685.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $1.33M derived: sum of 2 quarters · filed 2019-11-06 | $1.19M 10-Q · filed 2019-11-06 | $1.60M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-06-30 | $642.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $508.00K 10-Q · filed 2019-08-07 | $920.00K derived: sum of 3 quarters · filed 2020-02-27 | $801.00K derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-03-31 | -$134.00K 10-Q · filed 2019-05-08 | $278.00K derived: sum of 2 quarters · filed 2020-02-27 | $159.00K derived: sum of 3 quarters · filed 2020-02-27 | $184.00K derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2017-12-31 | $412.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $293.00K derived: sum of 2 quarters · filed 2020-02-27 | $318.00K derived: sum of 3 quarters · filed 2020-02-27 | $497.00K 10-K · filed 2020-02-27 | ||||
| 2017-09-30 | -$119.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$94.00K derived: sum of 2 quarters · filed 2018-11-08 | $85.00K 10-Q · filed 2018-11-08 | -$175.00K derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-06-30 | $25.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $204.00K 10-Q · filed 2018-08-08 | -$204.00K 10-Q · filed 2017-08-09 | -$56.00K derived: sum of 3 quarters · filed 2019-02-27 | $2.73M derived: sum of 4 quarters · filed 2019-02-27 | |||
| 2017-03-31 | $179.00K 10-Q · filed 2018-05-09 | -$179.00K 10-Q · filed 2017-05-10 | -$81.00K derived: sum of 2 quarters · filed 2019-02-27 | $2.71M derived: sum of 3 quarters · filed 2019-02-27 | ||||
| 2016-12-31 | -$260.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $2.53M derived: sum of 2 quarters · filed 2019-02-27 | $1.32M 10-K · filed 2019-02-27 | -$1.32M 10-K · filed 2017-03-10 | ||||
| 2016-09-30 | $2.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $1.58M 10-Q · filed 2017-11-08 | -$1.58M 10-Q · filed 2016-11-10 | |||||
| 2016-06-30 | -$1.21M 10-Q · filed 2017-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |